Compare Lustrum:Delta-Fly Pharma,Inc.:4598

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Delta-Fly Pharma,Inc. Go to web site 4598 Medicals 東証グロース March 1, 2000 2018.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Delta-Fly Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Balance Sheet 2025年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2024年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2023年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2022年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
339down
(78.0%)down
1,417up
(96.1%)up
844down
(93.1%)down
1,268down
(95.8%)down
2,089
(96.6%)
Other Current AssetsHelp
(Percent)
56up
(12.9%)up
16down
(1.1%)down
22up
(2.4%)up
12down
(0.9%)down
27
(1.2%)
Tangible Fixed AssetsHelp
(Percent)
37down
(8.5%)up
38down
(2.6%)down
39down
(4.3%)up
40down
(3.0%)up
42
(1.9%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
0
(0.0%)
Investments and OthersHelp
(Percent)
3down
(0.7%)up
3up
(0.2%)down
2down
(0.2%)down
4down
(0.3%)up
4
(0.2%)
Total AssetsHelp
(Percent)
434
(100%)
1,474
(100%)
907
(100%)
1,324
(100%)
2,161
(100%)
Total Current LiabilitiesHelp
(Percent)
157down
(36.0%)up
241up
(16.4%)up
116up
(12.7%)up
91up
(6.9%)up
82
(3.8%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
278down
(64.0%)down
1,233up
(83.6%)down
791down
(87.3%)down
1,233down
(93.1%)down
2,079
(96.2%)
Total LiabilitiesHelp
(Percent)
434
(100%)
1,474
(100%)
907
(100%)
1,324
(100%)
2,161
(100%)

Delta-Fly Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Profit and Loss Account 2025年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2024年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2023年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2022年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
-
(100%)
-
(100%)
0
(100%)
300
(100%)
300
(100%)
Total Sales
(Percent)
-
(100%)
-
(100%)
0
(100%)
300
(100%)
300
(100%)
Cost of SalesHelp
(Percent)

-

-

-

-

-
Other Costs and RevenueHelp 0
-
0
-
1,329up
1,267up
(422.4%)up
1,163
(387.5%)
Total CostsHelp 0 0 1,329 1,267 1,163
Net RevenueHelp
-

-

-

-

-
Earnings Before TaxHelp
-

-
-1,326down
-964down
(-321.4%)down
-859
(-286.5%)
Net IncomeHelp
-

-
-1,329down
-967down
(-322.4%)down
-863
(-287.5%)
当期純利益 - - -1,329 -967 -863

Delta-Fly Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Cash Flow Statement 2025年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2024年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2023年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2022年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
-1,835down
(-100.0%)down
-1,280up
(-69.0%)up
-1,303down
(-99.7%)up
-940down
(-100.0%)down
-727
(-83.0%)
Investing Cash Flow(ICF)Help
(Percent)
-0down
(0.0%)down
0up
(0.0%)up
-0
(0.0%)up
-0up
(0.0%)up
-1
(-0.1%)
Financing Cash FlowHelp
(Percent)
757down
(41.2%)down
1,853up
(100.0%)up
883up
(67.5%)up
120down
(12.7%)down
875
(100.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-0up
(0.0%)up
-1up
(-0.1%)up
-3down
(-0.3%)down
1up
(0.1%)up
-3
(-0.4%)
Net Increase and Decrease in Cash and Cash Equivalentsn -1,078down
(-58.8%)down
573up
(30.9%)up
-424up
(-32.5%)up
-820down
(-87.2%)down
145
(16.5%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Delta-Fly Pharma,Inc.

Company where related level is highHelp

HEALIOS K.K.
MIZUHO MEDY CO.,LTD.
Sumitomo Pharma Co., Ltd.
R-TECH UENO,LTD.
Fuso Pharmaceutical Industries, Ltd.
StemRIM Inc.
GNI Group Ltd.
Nissui Pharmaceutical Co.,Ltd.
KAINOS Laboratories,Inc.
Medrx Co.,Ltd.